Login / Signup

Dendrimer nanosystems for adaptive tumor-assisted drug delivery via extracellular vesicle hijacking.

Yifan JiangZhenbin LyuBrigino RalahyJuan LiuTom RousselLing DingJingjie TangArtemis KostaSuzanne GiorgioRichard TomasiniXing-Jie LiangNelson J DusettiJuan Lucio IovannaLing Peng
Published in: Proceedings of the National Academy of Sciences of the United States of America (2023)
Drug delivery systems (DDSs) that can overcome tumor heterogeneity and achieve deep tumor penetration are challenging to develop yet in high demand for cancer treatment. We report here a DDS based on self-assembling dendrimer nanomicelles for effective and deep tumor penetration via in situ tumor-secreted extracellular vesicles (EVs), an endogenous transport system that evolves with tumor microenvironment. Upon arrival at a tumor, these dendrimer nanomicelles had their payload repackaged by the cells into EVs, which were further transported and internalized by other cells for delivery "in relay." Using pancreatic and colorectal cancer-derived 2D, 3D, and xenograft models, we demonstrated that the in situ-generated EVs mediated intercellular delivery, propagating cargo from cell to cell and deep within the tumor. Our study provides a new perspective on exploiting the intrinsic features of tumors alongside dendrimer supramolecular chemistry to develop smart and effective DDSs to overcome tumor heterogeneity and their evolutive nature thereby improving cancer therapy.
Keyphrases
  • drug delivery
  • single cell
  • induced apoptosis
  • oxidative stress
  • mesenchymal stem cells
  • cell proliferation
  • cell therapy
  • signaling pathway